Introgen Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics

INGN 6.890

+0.1%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: zeta1961 who wrote (722)	5/4/2007 2:59:07 PM
From: Jibacoa	Read Replies (2) of 802

The Street.com talking about Advexin approval?. No, Talking about Provenge's approval. Sorry if I got you confused.<g> On the other hand,in INGN's 2006 Annual Report: " FROM PROMISE TO PRACTICE", it seems David Nance decided to spend a few extra bucks.<g> The first 4 pages before the 10-K are on good quality paper, listing its business strategy, list of products letter to shareholders & the paper of the 10-K isn't too bad either. Will see how the CC today comes out. I doubt I.F. et Al. will be there.<g> There have been some upticks in the last half hour. The question is if the stock will be able to trade above $4.80 AHs. If it does, will probably get above $5 on Monday. <g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next